We are live on ! Find out more
NDSI

Newman Dignan & Sheerar Inc Portfolio holdings

AUM $523M
1-Year Est. Return 26.16%
This Fund
S&P 500
This Quarter Est. Return
-0.44%
1 Year Est. Return
+26.16%
3 Year Est. Return
+73.46%
5 Year Est. Return
+76.54%
10 Year Est. Return
+279.61%
AUM
$346M
AUM Growth
+$49.4M
Cap. Flow
+$7.92M
Cap. Flow %
2.29%
Top 10 Hldgs %
42.9%
Holding
202
New
20
Increased
75
Reduced
60
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 11.79%
2 Healthcare 7.23%
3 Communication Services 5.47%
4 Financials 5.05%
5 Industrials 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOOG icon
176
Vanguard S&P 500 Growth ETF
VOOG
$27.2B
$221K 0.06%
4,980
PAYX icon
177
Paychex
PAYX
$42.7B
$219K 0.06%
+1,949
New +$219K
COST icon
178
Costco
COST
$420B
$213K 0.06%
+473
New +$208K
TEL icon
179
TE Connectivity
TEL
$62.6B
$213K 0.06%
1,550
-200
-11% -$28.9K
RSP icon
180
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$211K 0.06%
1,409
-80
-5% -$12.2K
IPAY icon
181
Amplify Mobile Payments ETF
IPAY
$182M
$210K 0.06%
3,097
NOC icon
182
Northrop Grumman
NOC
$81.2B
$202K 0.06%
560
CLSD
183
DELISTED
Clearside Biomedical
CLSD
$129K 0.04%
+1,435
New +$127K
OR icon
184
OR Royalties Inc
OR
$6.2B
$125K 0.04%
+11,139
New +$139K
ET icon
185
Energy Transfer Partners
ET
$69.3B
$115K 0.03%
+12,000
New +$115K
SNDL icon
186
Sundial Growers
SNDL
$320M
$69K 0.02%
+10,142
New +$79.2K
OVID icon
187
Ovid Therapeutics
OVID
$491M
$52K 0.02%
+15,522
New +$56.6K
HSTO
188
DELISTED
Histogen Inc. Common Stock
HSTO
$40K 0.01%
+2,626
New +$44.4K
MDNA
189
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$36K 0.01%
+12,915
New +$32K
APTO
190
DELISTED
Aptose Biosciences, Inc.
APTO
$28K 0.01%
+29
New +$36.3K
ONCY
191
Oncolytics Biotech
ONCY
$95.8M
$27K 0.01%
+12,915
New +$29.2K
SLDB icon
192
Solid Biosciences
SLDB
$900M
$24K 0.01%
+668
New +$28.4K
PTE
193
DELISTED
PolarityTE, Inc. Common Stock
PTE
$13K ﹤0.01%
+832
New +$16.1K
OGEN icon
194
Oragenics
OGEN
$2.48M
$7K ﹤0.01%
+6
New +$7.24K
ASHR icon
195
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
-15,369
Closed -$623K
CI icon
196
Cigna
CI
$74.6B
-859
Closed -$204K
CL icon
197
Colgate-Palmolive
CL
$74.4B
-2,520
Closed -$205K
FXI icon
198
iShares China Large-Cap ETF
FXI
$4.31B
-8,308
Closed -$385K
JAZZ icon
199
Jazz Pharmaceuticals
JAZZ
$16.7B
-1,300
Closed -$231K
JCI icon
200
Johnson Controls International
JCI
$92.2B
-3,015
Closed -$207K

Similar funds

Newman Dignan & Sheerar Inc's Q3 2021 Portfolio in Review

As of Q3 2021, Newman Dignan & Sheerar Inc held 202 positions worth $346M, up 17% from $297M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Newman Dignan & Sheerar Inc's Q3 2021 filing shows 20 new, 75 increased, 60 reduced and 7 closed positions. Its largest new stake was First Trust Preferred Securities and Income ETF: 317,127 shares worth $6.51M. The largest sale was State Street SPDR Bloomberg 1-10 Year TIPS ETF, an estimated $968K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Communication Services.

  • Newman Dignan & Sheerar Inc's largest Q3 2021 buy was First Trust Preferred Securities and Income ETF: 317,127 shares worth $6.51M.
  • Newman Dignan & Sheerar Inc added most to Applied Finance Valuation Large Cap ETF in Q3 2021, an estimated $1.64M increase.
  • Newman Dignan & Sheerar Inc's biggest Q3 2021 reduction was State Street SPDR Bloomberg 1-10 Year TIPS ETF, cutting an estimated $968K.
  • Newman Dignan & Sheerar Inc fully exited Xtrackers Harvest CSI 300 China A-Shares ETF in Q3 2021, selling an estimated $623K.
  • Newman Dignan & Sheerar Inc's ten largest holdings make up 43% of its $346M portfolio in Q3 2021.
  • Newman Dignan & Sheerar Inc opened 20 new positions and closed 7 in Q3 2021.
  • Newman Dignan & Sheerar Inc's portfolio value rose 17% quarter-over-quarter to $346M.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q3 2021, filed 7 Oct 2021.